MedPath

Conscious Sedation vs General Anesthesia in TAVR Patients

Not Applicable
Withdrawn
Conditions
Aortic Stenosis
Interventions
Procedure: General Anesthesia
Procedure: Conscious Sedation
Registration Number
NCT03084978
Lead Sponsor
Montefiore Medical Center
Brief Summary

This is a randomized controlled trial investigating the effect of general anesthesia versus conscious sedation on operative times in patients undergoing transcatheter aortic valve replacement.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Signed informed consent, signed Health Insurance Portability and Accountability Act (HIPAA) documentation)
  2. Age over 18 years of age.
  3. Women of child bearing age must have a negative urine or serum pregnancy test.
  4. Clinical indication for a transfemoral aortic valve replacement.
  5. English or Spanish speaking
  6. No evidence of neurological impairment as defined by a NIHSS ≤ 1 and modified Rankin scale (mRS) ≤ 2 within 7 days prior to randomization.
Exclusion Criteria
  1. BMI > 40
  2. Diagnosis of severe obstructive sleep apnea based on previous polysomnography, with severe defined as an apnea-hypopnea index (AHI) >30 episodes/hr.
  3. High risk for aspiration such as severe esophageal disease (e.g. achalasia, gastroparesis, etc).
  4. Inability to lie supine for more than 30 minutes.
  5. Marginal femoral vessels with concern for possible conversion to transapical or transaortic access.
  6. Patient refusal
  7. Patient involved in another research study
  8. Psychiatric condition precluding ability to provide informed consent
  9. History of clinical stroke within 3 months prior to randomization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
General AnesthesiaGeneral AnesthesiaSubjects will undergo general anesthesia with endotracheal intubation.
Conscious SedationConscious SedationSubjects will undergo conscious sedation anesthesia.
Primary Outcome Measures
NameTimeMethod
Time-on-table<1 day

* time to patient on table to surgical drapes down

* time to patient on table to when deemed safe for transport by anesthesiologist and surgeon

Secondary Outcome Measures
NameTimeMethod
Number of patients with serious adverse eventswithin 30 days

* deaths

* conversion from sedation to intubation

* hypersensitivity reactions

Length of staywithin 30 days

* ICU length of stay (days)

* Hospital length of stay (days)

Readmissionswithin 30 days

Number of patients readmitted within 30 days of initial procedure

Number of Patients with Valve Complicationswithin 30 days

* paravalvular leak on echocardiogram

* pacemaker requirement

* vascular complications requiring reintervention

* post-procedure requiring valve dilation

Contrast usage<1 day

Amount of contrast used in mL for procedure

Fluoroscopy time<1 day

Amount of time fluoroscopy used

© Copyright 2025. All Rights Reserved by MedPath